Indication

Severe ocular inflammation

Severe ocular inflammation is a sight-threatening clinical state characterized by high-grade immune-mediated or infectious inflammatory activity affecting ocular structures, most commonly within the uveal tract (anterior, intermediate, posterior, or panuveitis), sclera, cornea, or vitreous cavity. Read more about Severe ocular inflammation

18 drugs 17 manufacturers

Advertisement

Drugs that treat it

Common Severe ocular inflammation therapies.

Showing 10–18 of 18 drugs

Filter & compare in the drug finder →Opens the drug finder with Severe ocular inflammation preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Severe ocular inflammation.

Severe ocular inflammation is a sight-threatening clinical state characterized by high-grade immune-mediated or infectious inflammatory activity affecting ocular structures, most commonly within the uveal tract (anterior, intermediate, posterior, or panuveitis), sclera, cornea, or vitreous cavity.

It can manifest in pediatric and adult populations either as an isolated ophthalmic condition or as a manifestation of systemic autoimmune disorders, severe trauma, or invasive infection.

Pathophysiologically, disruption of the blood-ocular barrier leads to robust leukocytic infiltration, cytokine surge, and tissue edema.

Clinically, it is distinguished by marked visual compromise, intense ocular pain, photophobia, ciliary flush, and significant biomicroscopic findings such as dense anterior chamber cells and flare, hypopyon, prominent vitritis, or macular edema.

Personalize your experience

Follow Severe ocular inflammation and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it